These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22813645)

  • 1. Statistical considerations for the HPTN 052 Study to evaluate the effectiveness of early versus delayed antiretroviral strategies to prevent the sexual transmission of HIV-1 in serodiscordant couples.
    Chen YQ; Masse B; Wang L; Ou SS; Li X; Donnell D; McCauley M; Gamble T; Ribauldo HJ; Cohen MS; Fleming TR
    Contemp Clin Trials; 2012 Nov; 33(6):1280-6. PubMed ID: 22813645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral Therapy for the Prevention of HIV-1 Transmission.
    Cohen MS; Chen YQ; McCauley M; Gamble T; Hosseinipour MC; Kumarasamy N; Hakim JG; Kumwenda J; Grinsztejn B; Pilotto JH; Godbole SV; Chariyalertsak S; Santos BR; Mayer KH; Hoffman IF; Eshleman SH; Piwowar-Manning E; Cottle L; Zhang XC; Makhema J; Mills LA; Panchia R; Faesen S; Eron J; Gallant J; Havlir D; Swindells S; Elharrar V; Burns D; Taha TE; Nielsen-Saines K; Celentano DD; Essex M; Hudelson SE; Redd AD; Fleming TR;
    N Engl J Med; 2016 Sep; 375(9):830-9. PubMed ID: 27424812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.
    Grinsztejn B; Hosseinipour MC; Ribaudo HJ; Swindells S; Eron J; Chen YQ; Wang L; Ou SS; Anderson M; McCauley M; Gamble T; Kumarasamy N; Hakim JG; Kumwenda J; Pilotto JH; Godbole SV; Chariyalertsak S; de Melo MG; Mayer KH; Eshleman SH; Piwowar-Manning E; Makhema J; Mills LA; Panchia R; Sanne I; Gallant J; Hoffman I; Taha TE; Nielsen-Saines K; Celentano D; Essex M; Havlir D; Cohen MS;
    Lancet Infect Dis; 2014 Apr; 14(4):281-90. PubMed ID: 24602844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of HIV Transmission and the HPTN 052 Study.
    Cohen MS; Gamble T; McCauley M
    Annu Rev Med; 2020 Jan; 71():347-360. PubMed ID: 31652410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of HIV-1 infection with early antiretroviral therapy.
    Cohen MS; Chen YQ; McCauley M; Gamble T; Hosseinipour MC; Kumarasamy N; Hakim JG; Kumwenda J; Grinsztejn B; Pilotto JH; Godbole SV; Mehendale S; Chariyalertsak S; Santos BR; Mayer KH; Hoffman IF; Eshleman SH; Piwowar-Manning E; Wang L; Makhema J; Mills LA; de Bruyn G; Sanne I; Eron J; Gallant J; Havlir D; Swindells S; Ribaudo H; Elharrar V; Burns D; Taha TE; Nielsen-Saines K; Celentano D; Essex M; Fleming TR;
    N Engl J Med; 2011 Aug; 365(6):493-505. PubMed ID: 21767103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to Early Antiretroviral Therapy: Results From HPTN 052, a Phase III, Multinational Randomized Trial of ART to Prevent HIV-1 Sexual Transmission in Serodiscordant Couples.
    Safren SA; Mayer KH; Ou SS; McCauley M; Grinsztejn B; Hosseinipour MC; Kumarasamy N; Gamble T; Hoffman I; Celentano D; Chen YQ; Cohen MS;
    J Acquir Immune Defic Syndr; 2015 Jun; 69(2):234-40. PubMed ID: 26009832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral Therapy to Prevent HIV Acquisition in Serodiscordant Couples in a Hyperendemic Community in Rural South Africa.
    Oldenburg CE; Bärnighausen T; Tanser F; Iwuji CC; De Gruttola V; Seage GR; Mimiaga MJ; Mayer KH; Pillay D; Harling G
    Clin Infect Dis; 2016 Aug; 63(4):548-54. PubMed ID: 27208044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.
    Anglemyer A; Rutherford GW; Horvath T; Baggaley RC; Egger M; Siegfried N
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD009153. PubMed ID: 23633367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.
    Anglemyer A; Rutherford GW; Baggaley RC; Egger M; Siegfried N
    Cochrane Database Syst Rev; 2011 Aug; (8):CD009153. PubMed ID: 21833973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.
    Donnell D; Baeten JM; Kiarie J; Thomas KK; Stevens W; Cohen CR; McIntyre J; Lingappa JR; Celum C;
    Lancet; 2010 Jun; 375(9731):2092-8. PubMed ID: 20537376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.
    Anglemyer A; Rutherford GW; Egger M; Siegfried N
    Cochrane Database Syst Rev; 2011 May; (5):CD009153. PubMed ID: 21563172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral therapy for prevention of HIV transmission: implications for Europe.
    Cambiano V; O'Connor J; Phillips AN; Rodger A; Lodwick R; Pharris A; Lampe F; Nakagawa F; Smith C; van de Laar MJ
    Euro Surveill; 2013 Nov; 18(48):20647. PubMed ID: 24308982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study.
    Hallett TB; Baeten JM; Heffron R; Barnabas R; de Bruyn G; Cremin Í; Delany S; Garnett GP; Gray G; Johnson L; McIntyre J; Rees H; Celum C
    PLoS Med; 2011 Nov; 8(11):e1001123. PubMed ID: 22110407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies.
    Heffron R; Ngure K; Mugo N; Celum C; Kurth A; Curran K; Baeten JM
    J Acquir Immune Defic Syndr; 2012 Sep; 61(1):116-9. PubMed ID: 22595872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study.
    Babiker AG; Emery S; Fätkenheuer G; Gordin FM; Grund B; Lundgren JD; Neaton JD; Pett SL; Phillips A; Touloumi G; Vjechaj MJ;
    Clin Trials; 2013; 10(1 Suppl):S5-S36. PubMed ID: 22547421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 prevention for HIV-1 serodiscordant couples.
    Curran K; Baeten JM; Coates TJ; Kurth A; Mugo NR; Celum C
    Curr HIV/AIDS Rep; 2012 Jun; 9(2):160-70. PubMed ID: 22415473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Treatment-as-Prevention: A Cohort Study Analysis of Serodiscordant Couples in Rural Southwest China.
    Tang Z; Lan G; Chen YQ; Zhu Q; Yang X; Shen Z; Chen Y; Zhang H; Kan W; Xing H; Ruan Y; Shao Y
    Medicine (Baltimore); 2015 Jun; 94(24):e902. PubMed ID: 26091454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment as Prevention for HIV Infection: Current Data, Challenges, and Global Perspectives.
    Yombi JC; Mertes H
    AIDS Rev; 2018; 20(3):131-140. PubMed ID: 30264827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention.
    Mujugira A; Baeten JM; Donnell D; Ndase P; Mugo NR; Barnes L; Campbell JD; Wangisi J; Tappero JW; Bukusi E; Cohen CR; Katabira E; Ronald A; Tumwesigye E; Were E; Fife KH; Kiarie J; Farquhar C; John-Stewart G; Kidoguchi L; Panteleeff D; Krows M; Shah H; Revall J; Morrison S; Ondrejcek L; Ingram C; Coombs RW; Lingappa JR; Celum C;
    PLoS One; 2011; 6(10):e25828. PubMed ID: 21998703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment to Prevent HIV Transmission in Serodiscordant Couples in Henan, China, 2006 to 2012.
    Smith MK; Westreich D; Liu H; Zhu L; Wang L; He W; Zhou J; Miller WC; Cohen MS; Wang N
    Clin Infect Dis; 2015 Jul; 61(1):111-9. PubMed ID: 25770173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.